These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21163340)

  • 21. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
    Siepmann J; Siepmann F; Florence AT
    Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
    Chen SJ; Zhu JB
    Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers.
    Natu MV; de Sousa HC; Gil MH
    Int J Pharm; 2010 Sep; 397(1-2):50-8. PubMed ID: 20599485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Random walks on the Comb model and its generalizations.
    Arkhincheev VE
    Chaos; 2007 Dec; 17(4):043102. PubMed ID: 18163766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology.
    Shah SN; Asghar S; Choudhry MA; Akash MS; ur Rehman N; Baksh S
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1470-8. PubMed ID: 19929206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theoretical investigation of drug release from planar matrix systems: effects of a finite dissolution rate.
    Frenning G
    J Control Release; 2003 Oct; 92(3):331-9. PubMed ID: 14568413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled release from bioerodible polymers: effect of drug type and polymer composition.
    Frank A; Rath SK; Venkatraman SS
    J Control Release; 2005 Feb; 102(2):333-44. PubMed ID: 15653155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
    Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical factors in the release of drugs from sustained release hydrophilic matrices.
    Maderuelo C; Zarzuelo A; Lanao JM
    J Control Release; 2011 Aug; 154(1):2-19. PubMed ID: 21497624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing signal attenuation in PFG anomalous diffusion via a non-Gaussian phase distribution approximation approach by fractional derivatives.
    Lin G
    J Chem Phys; 2016 Nov; 145(19):194202. PubMed ID: 27875861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monte Carlo simulations of drug release from matrices with periodic layers of high and low diffusivity.
    Kosmidis K; Macheras P
    Int J Pharm; 2008 Apr; 354(1-2):111-6. PubMed ID: 18063328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers.
    Gurny R; Doelker E; Peppas NA
    Biomaterials; 1982 Jan; 3(1):27-32. PubMed ID: 7066463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrogels in controlled release formulations: network design and mathematical modeling.
    Lin CC; Metters AT
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1379-408. PubMed ID: 17081649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of nano drug carriers towards optimum release rate.
    Ng EY; Ng WK
    J Med Eng Technol; 2007; 31(4):243-52. PubMed ID: 17566928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
    Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
    Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
    Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet.
    Timmins P; Delargy AM; Howard JR
    Pharm Dev Technol; 1997 Feb; 2(1):25-31. PubMed ID: 9552428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monte Carlo simulations and fractional kinetics considerations for the Higuchi equation.
    Dokoumetzidis A; Kosmidis K; Macheras P
    Int J Pharm; 2011 Oct; 418(1):100-3. PubMed ID: 21130148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.